Multidisciplinary care improves outcome of patients with stage 5 chronic kidney disease

Nephron - Clinical Practice

Volumn 115, Issue 4, 2010, Pages

  Fenton, Anthony ^a   Sayar, Zara ^a   Dodds, Annette ^a   Dasgupta, Indranil ^a  

^a BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

Author keywords

Chronic kidney disease; Hospitalization; Multidisciplinary care; Outcomes; Survival

Indexed keywords

HEMOGLOBIN;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD PRESSURE; CALCIUM BLOOD LEVEL; CASE CONTROL STUDY; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HEMOGLOBIN DETERMINATION; HOSPITALIZATION; HUMAN; KAPLAN MEIER METHOD; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; MULTIDISCIPLINARY CARE; NEPHROLOGY; OUTCOME ASSESSMENT; PATIENT CARE; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME;

FEMALE; GREAT BRITAIN; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PATIENT CARE TEAM; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 77951228923     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000313487     Document Type: Article

References (33)

1. Gaede P, Vedel P, Parving HH, Pedersen O: Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminaemia: the Steno type 2 randomised study. Lancet 1999; 353: 617-622.
2. Norris SL, Nicholas PJ, Caspersen CJ, Glasgow RE, Engelgau MM, Jack L, Isham G, Snyder SR, Carande-Kulis VG, Garfield S, Briss P, McCulloch D: The effectiveness of disease and case management for people with diabetes. A systematic review. Am J Prev Med 2002; 22: 15-38.
3. Gabel M, Hilton NE, Nathanson SD: Multidisciplinary breast cancer clinics. Do they work? Cancer 1997; 79: 2380-2384.
4. Vliet Vlieland TP, Zwimderman AH, Vandenbroucke JP, Breedveld FC, Hazes JM: A randomised clinical trial of in-patient multidisciplinary treatment versus routine outpatient care in rheumatoid arthritis. Br J Rheumatol 1996; 35: 475-482.
5. Vliet Vlieland TP, Breedveld FC, Hazes JM: The two-year follow-up of a randomised comparison of in-patient multidisciplinary team care and routine out-patient care for active rheumatoid arthritis. Br J Rheumatol 1997; 36: 82-85.
6. McAlister FA, Lawson FM, Teo KK, Armstrong PW: A systematic review of randomized trials of disease management programs in heart failure. Am J Med 2001; 110: 378-384.
7. McDonald K, Ledwidge M, Cahill J, Quigley P, Maurer B, Travers B, Ryder M, Kieran E, Timmons L, Ryan E: Heart failure management: multidisciplinary care has intrinsic benefit above the optimization of medical care. J Card Fail 2002; 8: 142-148.
8. Levin A: The need for optimal and coordinated management of CKD. Kidney Int Suppl 2005; 99:S7-S10.
9. Barrett BJ: Applying multiple interventions in chronic kidney disease. Semin Dial 2003; 16: 157-164.
10. Mendelssohn DC: Coping with the CKD epidemic: the promise of multidisciplinary team-based care. Nephrol Dial Transplant 2005;20: 10-12.
11. Hemmelgarn BR, Manns BJ, Zhang J, Tonelli M, Klarenbach S, Walsh M, Culleton BF: Association between multidisciplinary care and survival for elderly patients with chronic kidney disease. J Am Soc Nephrol 2007; 18: 993-999.
12. Curtis BM, Ravani P, Malberti F, Kennet F, Taylor PA, Djurdjev O, Levin A: The shortand long-term impact of multidisciplinary clinic as in addition to standard nephrology care on patient outcomes. Nephrol Dial Transplant 2005; 20: 147-154.
13. Goldstein M, Yassa T, Dacouris N, McFarlane P: Multidisciplinary predialysis care and morbidity and mortality of patients on dialysis. Am J Kidney Dis 2004; 44: 706-714.
14. Innes A, Rowe PA, Burden RP, Morgan AG: Early deaths on renal replacement therapy: the need for early nephrological referral. Nephrol Dial Transplant 1992; 7: 467-471.
15. Roderick P, Jones C, Drey N, Blakeley S, Webster P, Goddard J, Garland S, Bourton L, Mason J, Tomson C: Late referral for endstage renal disease: a region-wide survey in the south west of England. Nephrol Dial Transplant 2002; 17: 1252-1259.
16. Jungers P, Massey ZA, Nguyen-Khoa T, Choukroun G, Robino C, Fakhouri F, Touam M, Nguyen AT, Grünfeld JP: Longer duration of predialysis nephrological care is associated with improved long-term survival of dialysis patients. Nephrol Dial Transplant 2001; 16: 2357-2364.
17. Gøransson LG, Bergrem H: Consequences of late referral of patients with end-stage renal disease. J Intern Med 2001; 250: 154-159.
18. Dogan E, Ercok R, Sayarlioglu H, Durmus A, Topal C: Effects of late referral to a nephrologist in patients with chronic renal failure. Nephrology (Carlton) 2005; 10: 516-519.
19. Peña JM, Logroño JM, Pernaute R, Laviades C, Virto R, Vicente de Vera C: Late nephrology referral influences on morbidity and mortality of hemodialysis patients. A provincial study (in Spanish). Nephrologia 2006; 26: 84-97.
20. Dhingra RK, Young EW, Hulbert-Shearon TE, Leavey SF, Port FK: Type of vascular access and mortality in US hemodialysis patients. Kidney Int 2001; 60: 1143-1151.
21. Di Iorio BR, Bellizzi V, Cillo N, Cirillo M, Avella F, Andreucci VE, De Santo NG: Vascular access for hemodialysis: the impact on morbidity and mortality. J Nephrol 2004; 17: 19-25.
22. Ortega T, Ortega F, Diaz-Corte C, Rebollo P, Ma Baltar J, Alvarez-Grande J: The timely construction of arteriovenous fistulae: a key to reducing morbidity and mortality and to improving cost management. Nephrol Dial Transplant 2005; 20: 598-603.
23. Astor BC, Eustace JA, Powe NR, Klag MJ, Fink NE, Coresh J; CHOICE Study: Type of vascular access and survival among incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study. J Am Soc Nephrol 2005; 16: 1449-1455.
24. Asif A, Lenz O, Merrill D, Pennell P: What should nephrologists do to maximize the use of arteriovenous fistulas? Semin Dial 2006; 19: 203-205.
25. Ansell D, Feest TG, Tomson C, Williams AJ, Warwick G: UK Renal Registry Report 2006. Bristol, UK Renal Registry, 2006.
26. Parfrey PS, Foley RN, Wittreich BH, Sullivan DJ, Zagari MJ, Frei D: Double-blind comparison of full and partial anemia correction in incident hemodialysis patients without symptomatic heart disease. J Am Soc Nephrol 2005; 16: 2180-2189.
27. Furuland H, Linde T, Ahlmén J, Christensson A, Strömbom U, Danielson BG: A randomized controlled trial of haemoglobin normalization with epoetin alfa in pre-dialysis and dialysis patients. Nephrol Dial Transplant 2003; 18: 353-361.
28. Foley RN, Parfrey PS, Morgan J, Barré PE, Campbell P, Cartier P, Coyle D, Fine A, Handa P, Kingma I, Lau CY, Levin A, Mendelssohn D, Muirhead N, Murphy B, Plante RK, Posen G, Wells GA: Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy. Kidney Int 2000; 58: 1325-1335.
29. Canadian Erythropoietin Study Group: Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. BMJ 1990; 300: 573-578.
30. Finkelstein FO, Story K, Firanek C, Mendelssohn D, Barre P, Takano T, Soroka S, Mujais S: Health-related quality of life and hemoglobin levels in chronic kidney disease patients. Clin J Am Soc Nephrol 2008; 4: 33-38.
31. Alexander M, Kewalramani R, Agodoa I, Globe D: Association of anemia correction with health related quality of life in patients not on dialysis. Curr Med Res Opin 2007; 23: 2997-3008.
32. Perlman RL, Finkelstein FO, Liu L, Roys E, Kiser M, Eisele G, Burrows-Hudson S, Messana JM, Levin N, Rajagopalan S, Port FK, Wolfe RA, Saran R: Quality of life in chronic kidney disease (CKD): a cross-sectional analysis in the Renal Research Institute- CKD study. Am J Kidney Dis 2005; 45: 658-666.
33. Shariff SZ, Cuerden MS, Jain AK, Garg AX: The secret of immortal time bias in epidemiologic studies. J Am Soc Nephrol 2008; 19: 841-843.